FDA Is Pharma's Lapdog, Not a Watchdog
Story at-a-glance
- The House Energy and Commerce Committee launched an investigation into the FDA’s Office of Criminal Investigations (OCI), particularly their handling of food, drug and medical device cases
- A Reuters investigation previously found that more than half of all OCI cases are closed with no action taken
- Agents at OCI have said they were told to avoid opening cases relating to other federal agencies
- OCI agents have also questioned the need to pursue mislabeled injectable drugs, like Botox, from other countries, seemingly protecting high drug prices in the U.S. even though such drugs pose little public health risk
No comments:
Post a Comment